Literature DB >> 12802682

Recombinant Duffy binding-like-alpha domains of Plasmodium falciparum erythrocyte membrane protein 1 elicit antibodies in rats that recognise conserved epitopes.

Raphael M Oguariri1, Denise Mattei, Cristina Tena-Tomás, Anne-Catrin Uhlemann, Peter G Kremsner, Jürgen F J Kun.   

Abstract

Plasmodium falciparum parasites remodel the surface of human erythrocytes on invasion by the insertion of parasite-derived proteins in knob-like protrusions. P. falciparum erythrocyte membrane protein 1 (PfEMP-1), a variant surface antigen, has been shown to be anchored in these knobs and mediates adhesion to various host endothelial receptors. These proteins also undergo clonal antigenic variation as a means of immune evasion. Duffy binding-like-alpha(DBL-alpha) domain together with the cysteine-rich interdomain region form the head structure of the PfEMP1 molecule. In this report, we used ten different recombinant DBL-alpha fusion proteins expressed in Escherichia coli to generate antibodies in experimental animals. Five out of ten recombinant DBL-alpha fusion proteins were immunogenic and induced antibodies that reacted with conserved peptides derived from PfEMP1. Indirect immunofluorescence assay was used to localise PfEMP-1-DBL-alpha expressed in parasitised erythrocytes. Positive fluorescence reactivity was observed within the cytoplasm and with membrane structures but not on the surface of intact P. falciparum-infected erythrocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12802682     DOI: 10.1007/s00436-003-0884-8

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  28 in total

1.  MESA is a Plasmodium falciparum phosphoprotein associated with the erythrocyte membrane skeleton.

Authors:  R L Coppel; S Lustigman; L Murray; R F Anders
Journal:  Mol Biochem Parasitol       Date:  1988-12       Impact factor: 1.759

2.  Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

Authors:  C F Ockenhouse; P F Sun; D E Lanar; B T Wellde; B T Hall; K Kester; J A Stoute; A Magill; U Krzych; L Farley; R A Wirtz; J C Sadoff; D C Kaslow; S Kumar; L W Church; J M Crutcher; B Wizel; S Hoffman; A Lalvani; A V Hill; J A Tine; K P Guito; C de Taisne; R Anders; W R Ballou
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

3.  Targeted gene disruption shows that knobs enable malaria-infected red cells to cytoadhere under physiological shear stress.

Authors:  B S Crabb; B M Cooke; J C Reeder; R F Waller; S R Caruana; K M Davern; M E Wickham; G V Brown; R L Coppel; A F Cowman
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria.

Authors:  R F Anders
Journal:  Parasite Immunol       Date:  1986-11       Impact factor: 2.280

6.  A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts.

Authors:  A Birkett; K Lyons; A Schmidt; D Boyd; G A Oliveira; A Siddique; R Nussenzweig; J M Calvo-Calle; E Nardin
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

8.  Cryptic disposition of antigenic parasite proteins in plasma membranes of erythrocytes infected with Plasmodium chabaudi.

Authors:  F Wunderlich; M Helwig; G Schillinger; V Speth
Journal:  Mol Biochem Parasitol       Date:  1988-07       Impact factor: 1.759

9.  cDNA cloning and expression of Rhodnius prolixus vitellogenin.

Authors:  D Valle; J Kun; J Linss; E de S Garcia; S Goldenberg
Journal:  Insect Biochem Mol Biol       Date:  1993-06       Impact factor: 4.714

10.  Antibody recognition of Plasmodium falciparum erythrocyte surface antigens in Kenya: evidence for rare and prevalent variants.

Authors:  P C Bull; B S Lowe; M Kortok; K Marsh
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more
  9 in total

1.  Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication.

Authors:  Raphael M Oguariri; Joseph W Adelsberger; Michael W Baseler; Tomozumi Imamichi
Journal:  Virus Res       Date:  2010-08-26       Impact factor: 3.303

2.  Evaluation of the effectiveness and compliance of intermittent preventive treatment (IPT) in the control of malaria in pregnant women in south eastern Nigeria.

Authors:  F O Nduka; E Nwosu; R M Oguariri
Journal:  Ann Trop Med Parasitol       Date:  2011-12

3.  The impact of IgG antibodies to recombinant Plasmodium falciparum 732var CIDR-1alpha domain in mothers and their newborn babies.

Authors:  Ayman Khattab; Yu-Shan Chia; Jürgen May; Jean-Yves Le Hesran; Philippe Deloron; Mo-Quen Klinkert
Journal:  Parasitol Res       Date:  2007-05-23       Impact factor: 2.289

4.  Functional and immunological characterization of a Duffy binding-like alpha domain from Plasmodium falciparum erythrocyte membrane protein 1 that mediates rosetting.

Authors:  Alfredo Mayor; Eduard Rovira-Vallbona; Anand Srivastava; Surya K Sharma; Sudhanshu S Pati; Laura Puyol; Llorenç Quinto; Quique Bassat; Sonia Machevo; Inacio Mandomando; Virander S Chauhan; Pedro L Alonso; Chetan E Chitnis
Journal:  Infect Immun       Date:  2009-06-22       Impact factor: 3.441

5.  Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.

Authors:  Ashfaq Ghumra; Pongsak Khunrae; Ricardo Ataide; Ahmed Raza; Stephen J Rogerson; Matthew K Higgins; J Alexandra Rowe
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

6.  Allelic diversity of the Plasmodium falciparum erythrocyte membrane protein 1 entails variant-specific red cell surface epitopes.

Authors:  Inès Vigan-Womas; Micheline Guillotte; Alexandre Juillerat; Cindy Vallieres; Anita Lewit-Bentley; Adama Tall; Laurence Baril; Graham A Bentley; Odile Mercereau-Puijalon
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

7.  Using the PfEMP1 head structure binding motif to deal a blow at severe malaria.

Authors:  Manuel E Patarroyo; Martha Patricia Alba; Hernando Curtidor; Magnolia Vanegas; Hannia Almonacid; Manuel A Patarroyo
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

Review 8.  Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates.

Authors:  Jo-Anne Chan; Freya J I Fowkes; James G Beeson
Journal:  Cell Mol Life Sci       Date:  2014-04-02       Impact factor: 9.261

Review 9.  The role of PfEMP1 as targets of naturally acquired immunity to childhood malaria: prospects for a vaccine.

Authors:  Peter C Bull; Abdirahman I Abdi
Journal:  Parasitology       Date:  2016-01-07       Impact factor: 3.234

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.